UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041595
Receipt number R000047480
Scientific Title Exploratory research of molecules contained in exosomes secreted from lung cancer
Date of disclosure of the study information 2020/08/28
Last modified on 2020/08/28 15:26:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory research of molecules contained in exosomes secreted from lung cancer

Acronym

Analysis of exosomes in lung cancer

Scientific Title

Exploratory research of molecules contained in exosomes secreted from lung cancer

Scientific Title:Acronym

Analysis of exosomes in lung cancer

Region

Japan


Condition

Condition

lung cancer

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To find new markers for treatment of lung cancer by analyzing exosomes.

Basic objectives2

Others

Basic objectives -Others

To research whether or not exosomes can be markers for treatment index of lung cancer.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Search of molecular markers in lung cancer specific exosomes.

Key secondary outcomes

Correlation with postoperative recurrence and exosomes.
Correlation with therapeutic effect in postoperative recurrence and exosomes.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A person falling under any of the following;
(i) Patients who will undergo radical surgery for lung cancer and were confirmed lung cancer in pathological diagnosis.
(ii) Patients with recurrence after undergoing radical surgery for lung cancer.
(iii) Patients with progressive disease treated alone or with combination of chemotherapy, radiation therapy and immunotherapy after undergoing radical surgery for lung cancer.
(iv) Healthy person with no history of diagnosis or treatment of malignant tumors

Key exclusion criteria

A person falling under any of the following;
(i) Patients who are diagnosed not to have lung cancer in postoperative pathologic diagnosis although patients were registered by key inclusion criteria (i).
(ii) Patients who are determined to be ineligible as human research subjects by researchers.

Target sample size

260


Research contact person

Name of lead principal investigator

1st name Kimikazu
Middle name
Last name Hamano

Organization

Yamaguchi University

Division name

Department of Surgery and Clinical Science

Zip code

7558505

Address

1-1-1, Minami-kogushi, ube, Japan

TEL

0836-22-2261

Email

cres-sg1@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Junichi
Middle name
Last name Murakami

Organization

Yamaguchi University

Division name

Department of Surgery and Clinical Science

Zip code

7558505

Address

1-1-1, Minami-kogushi, ube, Japan

TEL

0836-22-2261

Homepage URL


Email

cres-sg1@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Center for Clinical Research, Yamaguchi University Hospital

Address

1-1-1, Minami-kogushi, ube, Japan

Tel

0836-22-2428

Email

me223@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 08 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 07 Month 02 Day

Date of IRB

2020 Year 08 Month 28 Day

Anticipated trial start date

2020 Year 08 Month 28 Day

Last follow-up date

2032 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

1. Background of human research subject
2. Surgery related factors
3. Pathological factors
4. Post-operative factor
5. Analysis items in this research


Management information

Registered date

2020 Year 08 Month 28 Day

Last modified on

2020 Year 08 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047480


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name